Addex Pharmaceuticals Signs Three Year Clinical Development Partnership With Fulcrum Pharma Plc
10/19/2005 5:09:30 PM
Addex Pharmaceuticals SA, the drug development company focused on addiction and other central nervous system disorders, is pleased to announce the signing of a three year partnership with Fulcrum Pharma PLC (AIM: FUL), the drug development and strategic outsourcing services company. The three year agreement is the first preferred supplier arrangement in which Fulcrum takes an equity stake in its partner and receives fees for service.
comments powered by